Literature DB >> 27925266

Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Maria Letizia Ciavatta1, Florence Lefranc2, Marianna Carbone1, Ernesto Mollo1, Margherita Gavagnin1, Tania Betancourt3, Ramesh Dasari3, Alexander Kornienko3, Robert Kiss4.   

Abstract

The chemical investigation of marine mollusks has led to the isolation of a wide variety of bioactive metabolites, which evolved in marine organisms as favorable adaptations to survive in different environments. Most of them are derived from food sources, but they can be also biosynthesized de novo by the mollusks themselves, or produced by symbionts. Consequently, the isolated compounds cannot be strictly considered as "chemotaxonomic markers" for the different molluscan species. However, the chemical investigation of this phylum has provided many compounds of interest as potential anticancer drugs that assume particular importance in the light of the growing literature on cancer biology and chemotherapy. The current review highlights the diversity of chemical structures, mechanisms of action, and, most importantly, the potential of mollusk-derived metabolites as anticancer agents, including those biosynthesized by mollusks and those of dietary origin. After the discussion of dolastatins and kahalalides, compounds previously studied in clinical trials, the review covers potentially promising anticancer agents, which are grouped based on their structural type and include terpenes, steroids, peptides, polyketides and nitrogen-containing compounds. The "promise" of a mollusk-derived natural product as an anticancer agent is evaluated on the basis of its ability to target biological characteristics of cancer cells responsible for poor treatment outcomes. These characteristics include high antiproliferative potency against cancer cells in vitro, preferential inhibition of the proliferation of cancer cells over normal ones, mechanism of action via nonapoptotic signaling pathways, circumvention of multidrug resistance phenotype, and high activity in vivo, among others. The review also includes sections on the targeted delivery of mollusk-derived anticancer agents and solutions to their procurement in quantity.
© 2016 The Authors Medicinal Research Reviews Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  innovative mechanism of action; mollusk; cancer; preclinical evaluation; targeted delivery; treatment

Mesh:

Substances:

Year:  2016        PMID: 27925266      PMCID: PMC5484305          DOI: 10.1002/med.21423

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  471 in total

1.  Isolation and Stereostructures of Dolastatin G and Nordolastatin G, Cytotoxic 35-Membered Cyclodepsipeptides from the Japanese Sea Hare Dolabella auricularia.

Authors:  Tsuyoshi Mutou; Takashi Kondo; Makoto Ojika; Kiyoyuki Yamada
Journal:  J Org Chem       Date:  1996-09-06       Impact factor: 4.354

Review 2.  Importance of RhoGTPases in formation, characteristics, and functions of invadosomes.

Authors:  Pirjo Spuul; Paolo Ciufici; Véronique Veillat; Anne Leclercq; Thomas Daubon; IJsbrand Kramer; Elisabeth Génot
Journal:  Small GTPases       Date:  2014-05-08

Review 3.  Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair.

Authors:  Timothy L Scott; Suganya Rangaswamy; Christina A Wicker; Tadahide Izumi
Journal:  Antioxid Redox Signal       Date:  2013-10-15       Impact factor: 8.401

4.  Cytotoxic and genotoxic effects of tambjamine D, an alkaloid isolated from the nudibranch Tambja eliora, on Chinese hamster lung fibroblasts.

Authors:  Bruno C Cavalcanti; Hélio V N Júnior; Mirna H R Seleghim; Roberto G S Berlinck; Geanne M A Cunha; Manoel O Moraes; Claudia Pessoa
Journal:  Chem Biol Interact       Date:  2008-06-23       Impact factor: 5.192

5.  Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis.

Authors:  Francis Robert; Hong Qing Gao; Marwa Donia; William C Merrick; Mark T Hamann; Jerry Pelletier
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

7.  Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties.

Authors:  B Kunze; R Jansen; F Sasse; G Höfle; H Reichenbach
Journal:  J Antibiot (Tokyo)       Date:  1995-11       Impact factor: 2.649

Review 8.  Paul Ehrlich's magic bullet concept: 100 years of progress.

Authors:  Klaus Strebhardt; Axel Ullrich
Journal:  Nat Rev Cancer       Date:  2008-05-12       Impact factor: 60.716

9.  Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.

Authors:  Rebecca Lamb; Hannah Harrison; James Hulit; Duncan L Smith; Michael P Lisanti; Federica Sotgia
Journal:  Oncotarget       Date:  2014-11-30

10.  CellMiner: a relational database and query tool for the NCI-60 cancer cell lines.

Authors:  Uma T Shankavaram; Sudhir Varma; David Kane; Margot Sunshine; Krishna K Chary; William C Reinhold; Yves Pommier; John N Weinstein
Journal:  BMC Genomics       Date:  2009-06-23       Impact factor: 3.969

View more
  19 in total

Review 1.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

Review 2.  High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview.

Authors:  Kajal Chakraborty; Minju Joy
Journal:  Food Res Int       Date:  2020-08-31       Impact factor: 6.475

Review 3.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

4.  The Ethyl Acetate Extract of the Marine Edible Gastropod Haliotis tuberculata coccinea: a Potential Source of Bioactive Compounds.

Authors:  Emiliana Tortorella; Rosa Giugliano; Marleen De Troch; Bruno Vlaeminck; Gercende Courtois de Viçose; Donatella de Pascale
Journal:  Mar Biotechnol (NY)       Date:  2021-10-29       Impact factor: 3.619

Review 5.  Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.

Authors:  Srimanta Patra; Prakash Priyadarshi Praharaj; Debasna Pritimanjari Panigrahi; Biswajit Panda; Chandra Sekhar Bhol; Kewal Kumar Mahapatra; Soumya Ranjan Mishra; Bishnu Prasad Behera; Mrutyunjay Jena; Gautam Sethi; Shankargouda Patil; Samir Kumar Patra; Sujit Kumar Bhutia
Journal:  Mol Biol Rep       Date:  2020-08-14       Impact factor: 2.316

Review 6.  Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications.

Authors:  Giovanna Romano; Mariana Almeida; Ana Varela Coelho; Adele Cutignano; Luis G Gonçalves; Espen Hansen; Denis Khnykin; Tali Mass; Andreja Ramšak; Miguel S Rocha; Tiago H Silva; Michela Sugni; Loriano Ballarin; Anne-Marie Genevière
Journal:  Mar Drugs       Date:  2022-03-22       Impact factor: 6.085

7.  Anti-Inflammatory Activity and Structure-Activity Relationships of Brominated Indoles from a Marine Mollusc.

Authors:  Tarek B Ahmad; David Rudd; Joshua Smith; Michael Kotiw; Peter Mouatt; Lisa M Seymour; Lei Liu; Kirsten Benkendorff
Journal:  Mar Drugs       Date:  2017-05-06       Impact factor: 5.118

8.  Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer.

Authors:  Tugba Yildiz; Renpeng Gu; Stefan Zauscher; Tania Betancourt
Journal:  Int J Nanomedicine       Date:  2018-10-31

Review 9.  The Potential of Indonesian Heterobranchs Found around Bunaken Island for the Production of Bioactive Compounds.

Authors:  Katja M Fisch; Cora Hertzer; Nils Böhringer; Zerlina G Wuisan; Dorothee Schillo; Robert Bara; Fontje Kaligis; Heike Wägele; Gabriele M König; Till F Schäberle
Journal:  Mar Drugs       Date:  2017-12-07       Impact factor: 5.118

Review 10.  Marine Natural Peptides: Determination of Absolute Configuration Using Liquid Chromatography Methods and Evaluation of Bioactivities.

Authors:  Ye' Zaw Phyo; João Ribeiro; Carla Fernandes; Anake Kijjoa; Madalena M M Pinto
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.